Share this Post!

The Food and Drug Administration (FDA), in its commitment to provide stakeholders with streamlined and improved government services, has issued FDA Circular No. 2020-030 on 16 October 2020 as implementing guideline in the application for License to Operate (LTO) of Drug Non-Manufacturing Establishments in the eServices Portal System.

Starting 26 October 2020, the FDA shall now accept LTO application (Initial, Renewal, and Variation) of the following Drug Establishments nationwide:

The eServices Portal System is accessible through this website:

The ePortal System shall remain online for Drug Establishments with on-going/in-process LTO applications and Drug Manufacturer LTO applications.

For information and guidance.


Attachment:->  Full Implementation of eServices Portal System for License to Operate (LTO)